URINARY BLADDER NEOPLASM
Clinical trials for URINARY BLADDER NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER NEOPLASM trials appear
Sign up with your email to follow new studies for URINARY BLADDER NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo could help bladder cancer patients keep their bladder
Disease control Recruiting nowThis study is testing whether giving two immunotherapy drugs before surgery can shrink bladder tumors enough to avoid removing the bladder entirely. The trial will enroll 90 adults with muscle-invasive bladder cancer who are not receiving standard chemotherapy. Researchers will c…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Breast cancer drugs repurposed in fight against rare tumors
Disease control Recruiting nowThis UK trial is testing if a drug combination already approved for breast cancer can help control other cancers with a specific genetic feature. It aims to treat adults and children (12+) with rare cancers or common cancers that have a rare genetic change called HER2. The goal i…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New 'Smart Bomb' drug seeks to target multiple advanced cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new investigational drug called LY4052031 for people with advanced or metastatic solid tumors. The drug is designed to target a specific protein found on many cancer cells, delivering its medicine dire…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New cancer drug enters human testing for multiple advanced tumors
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called LY4101174. Researchers want to find a safe dose and see if it can help control advanced cancers that have spread or returned after other treatments. The study will enroll about 490 people with various solid tumor…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC